The urokinase receptor is required for human monocyte chemotaxis in vitro

Journal of Clinical Investigation

Volumn 93, Issue 4, 1994, Pages 1380-1387

  Gyetko, Margaret R ^a,b   Todd III, Robert F ^a   Wilkinson, Camille C ^a   Sitrin, Robert G ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

antisense oligonucleotides; macrophage; mononuclear phagocyte; motility; plasminogen activators

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CELL SURFACE RECEPTOR; MATRIX PROTEIN; UROKINASE;

ANTIBODY LABELING; ARTICLE; CATALYSIS; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CHEMOTAXIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; STATISTICAL ANALYSIS;

EID: 0028331139     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117114     Document Type: Article

References (61)

1. Wilkinson, P., and W. Haston. 1988. Chemotaxis: an overview. Methods Enzymol. 162:3-16.
2. Lauffenburger, D. 1991. Models for receptor-mediated cell phenomena: adhesion and migration. Annu. Rev. Biophys. Biophys. Chem. 20:387-414.
3. Danø, K., P. A. Andreasen, J. Grendahi-Hansen, P. Kristensen, L. S. Nielsen, and L. Skriver. 1985. Plasminogen activators, tissue degradation, and cancer Adv. Cancer Res. 44:139-266.
4. Kirchheimer, J. C., and H. G. Remold. 1989. Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes. J. Immunol. 143:2634-2639.
5. Huber, A. R., and S. J. Weiss. 1989. Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall. J. Clin. Invest. 83:1122-1136.
6. Liotta, L. A., R. H. Goldfarb, R. Brundange, G. P. Siegal, V. Terranova, and S. Garbisa. 1981. Effect of plasminogen activator ( urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 41:4629-4636.
7. Kirchheimer, J. C., and H. G. Remold. 1989. Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors. Blood. 74:1396-1402.
8. Vassalli, J.-D., J.-M., Dayer, A. Wohlwend, and D. Belin. 1984. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J. Exp. Med. 159:1653-1668.
9. Vassalli, J.-D., A. P. Sappino, and D. Belin. 1991.The plasminogen activator/plasmin system. J. Clin Invest. 88:1067-1072.
10. Estreicher, A., J. Mühlhauser, J.-L. Carpentier, L. Orci, and J. D. Vassalli. 1990. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol. 111:783-792.
11. Miller, M., and M. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12:17-46.
12. Stossel, T. P. 1993. On the crawling of animal cells. Science (Wash. DC) 260:1086-1094.
13. Pöllänen, J., K. Hedman, L. S. Nielsen, K. Dane, and A. Vaheri. 1988. Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J. Cell Biol. 106:87-95.
14. Takahashi, K., K. Ikeo. T. Gojobori, and M. Tanifuji. 1990. Local function of urokinase receptor at the adhesion contact sites of a metastatic tumor cell. Thromb. Res (Suppl. 10):55-61.
15. Ciambrone, G. J., and P. J. McKeown-Longo. 1990. Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells. J. Cell Biol. 111:2183-2195.
16. Pepper, M. S., A.-P. Sappino, R. Stocklin, R. Montesano, L. Orci, and J.-D. Vassalli. 1993. Upregulation of urokinase receptor expression on migrating endothelial cells. J. Cell Biol. 122:673-684.
17. Liu, D., and R. Todd. 1986. A monoclonal antibody specific for a monocyte-macrophage membrane component blocks the human monocyte response to migration inhibitory factor. J. Immunol. 137:448-455.
18. Gold, L. I., A. Rostangno, B. Frangione, andT. Passalaris. 1992. Localization of the cleavage sites on fibronectin following digestion by urokinase. J. Cell. Biochem. 50:441-452.
19. Wainberg, M. A., E. Israel, and R. G. Margolese. 1982. Further studies on the mitogenic and immune-modulating effects of plasminogen activator. Immunology. 45:715-720.
20. Boyle, M. D. P., V. A. Chiodo, M. J. P. Lawman, A. P. Gee, and M. Young. 1987. Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol. 139:169-174.
21. Keski-Oja, J., J. Lohi, A. Tuuttila, K. Tryggvason, and T. Vartio. 1992. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Exp. Cell Res. 202:471-476.
22. Matsushima, K., M. Taguchi, E. J. Kovacs, H. A. Young, and J. J. Oppenheim. 1986. Intracellular localization of human monocyte associated interleukin-1 (IL-1) activity and release of biologically active IL-1 from monocytes by trypsin and plasmin. J. Immunol. 136:2883-2891.
23. Nusrat, A. R., and H. A. Chapman, Jr. 1991. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J. Clin. Invest. 87:1091-1097.
24. Kramer, M. D., U. Vettel, M. Schmitt, J. Reinartz, G. Brunner, and A. Meissauer. 1993. Monoclonal antibodies against plasminogen activators and plasmin (ogen). Fibrinolysis. 6:103-111.
25. Min, H., R. Semnani, I. Mizukami, K. Watt, R. Todd, and D. Liu. 1992. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J. Immunol. 148:3636-3642.
26. Mizukami, I., S. Vinjamuri, R. Trochelman, and R. Todd. 1990. A structural characterization of the Mo3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. J. Immunol. 144:1841-1848.
27. Todd, R., P. Alvarez, D. Brott, and D. Liu. 1985. Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e. J. Immunol. 135:3869-3877.
28. Todd, R. I., S. Meuer, P. Romain, and S. Schlossman. 1984. A monoclonal antibody that blocks class II histocompatibility related immune interactions. Hum. Immunol. 10:23-40.
29. Goldstein, S., and R. I. Todd. 1993. Mo5, a novel plasma membrane antigen synthesized by mature polymorphonuclear neutrophils: basic structural and biosynthetic features. Tissue Antigens. 41:214-218.
30. Dana, N., B. Styrt, J. Griffin, R. Todd III, M Klempner, and M. Arnaout. 1986. Two functional domains in the phagocyte membrane glycoprotein Mol identified are monoclonal antibodies. J. Immunol. 137:3259-3263.
31. Riccio, A., G. Grimaldi, P. Verde, G. Sebastio, S. Boast, and F. Blasi. 1985. The human urokinase-plasminogen activator gene and its promoter. Nucleic Acids Res. 13:2759-2771.
32. Roldan, A., M. Cubellis, M. Masucci, N. Behrendt, L. Lund, K. Dano, E. Appella, and F. Blasi. 1990. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO (Eur. Mol. Biol. Organ.). 9:467-474.
33. Stein, C. A., and J. S. Cohen. 1989. Phosphorothioate oligonucleotide analogues. In Oligodeoxynucleotides, Antisense Inhibitors of Gene Expression. J. S. Cohen, editor. CRC Press Inc., Boca Raton. 97-117.
34. Zar, J. H. 1984. Biostatistical Analysis. Prentice Hall Press, Englewood Cliffs, NJ. 121-129.
35. Chapman, H. A., Z. Vavrin, and J. B. Hibbs. 1982. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and an inhibitor of plasminogen activator. Cell. 28:654-662.
36. Moscatelli, D., and D. B. Rifkin. 1988. Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim. Biophys. Acta. 948:67-85.
37. Ossowski, L., H. Russo-Payne, and E. L. Wilson. 1991. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse. Cancer Res. 51:274-281.
38. Chapman, H. A., Jr., O. L. Stone, and Z. Vavrin. 1984. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation. J. Clin. Invest. 73:806-815.
39. Senior, R., and S. Shapiro. 1992. Introduction: the matrix metalloproteinase family. Am. J. Respir. Cell Mol. Biol. 7:119-127.
40. Mochan, E., and T. Keler. 1984. Plasmin degradation of cartilage proteoglycan. Biochim. Biophys. Acta. 800:312-315.
41. Remold-O'Donnell, E., and B. Savage. 1988. Purification, composition, and structure of macrophage adhesion molecule. Biochemistry. 27:42-45.
42. Manchanda, N., and B. Schwartz. 1991. Single chain urokinase: augmentation of enzymatic activity upon binding to monocytes. J. Biol. Chem. 266:14580-14584.
43. Dumler, I., T. Petri, and W. D. Schkeuning. 1993. Interaction of urokinase-type plasminogen activator (u-PA) with its cellular receptor (uPAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS (Fed. Eur. Biochem. Soc.) Lett. 322:37-40.
44. Stafanova, I., V. Horejsi, I. J. Ansotegui, W. Knapp, and H. Stockinger. 1991. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science (Wash. DC) 254:1016-1018.
45. Hansson, G. K., L. Jonasson, P. S. Seifert, and S. Stemme. 1989. Immune mechanisms in atherosclerosis. Arteriosclerosis. 9:567-578.
46. Saksela, O., T. Hovi, and A. Vaheri. 1985. Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages. J. Cell. Physiol. 122:125-132.
47. Stefanova, I., and V. Horejsi. 1991. Association of the CD59 and CD55 cell surface glycoproteins with other membrane molecules. J. Immunol. 147:1587-1592.
48. Davis, S., T. H. Aldrich, D. M. Valenzuela, V. Wong, M. E. Furth, S. P. Squinto, and G. D. Yancopoulos. 1991. The receptor for ciliary neurotrophic factor. Science (Wash. DC). 253:59-63.
49. Hibi, M., M. Murakami, M. Saito, T. Hirano, T. Taga, and T. Kishimoto. 1990. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 63:1149-1157.
50. Taga, T., M. Hibi, Y. Hirata, K. Yamasaki, K. Yasukawa, T. Matsuda, T. Hirano, and T. Kishimoto. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 58:573-581.
51. Davies, P. F. 1986. Vascular cell interactions with special reference to the pathogenesis of atherosclerosis. Lab. Invest. 55:5-24.
52. Petty, H. R., and T. F. Todd. 1993. Receptor-receptor interactions of complement receptor type 3 in neutrophil membranes. J. Leukocyte Biol. 54:492-494.
53. Xue, W., A. Kindzelsky, R. F. I. Todd, and H. R. Petty. 1993. Co-capping of mCR3 with the urokinase receptor. J. Immunol. 150:308a. (Abstr.)
54. Furfaro, S., and J. Berman. 1992. The relation between cell migration and activation in inflammation: beyond adherence. Am. J. Respir. Cell Mol. Biol. 7:248-250.
55. Zetter, B., and S. Brightman. 1990. Cell motility and the extracellular matrix. Cell Biol. 2:850-856.
56. Juliano, R. 1987. Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochim. Biophys. Acta. 907:261-278.
57. Keski-Oja, J., R. M. Lyons, and H. L. Moses. 1987. Inactive secreted forms of transforming growth factor β: activation by proteolysis. J. Cell. Biochem. Suppl. 11:60a. (Abstr.)
58. Saksela, O., and D. B. Rifkin. 1990. Release of basic fibroblast growth factor-heparin sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol. 110:767-775.
59. Naldini, L., L. Tamagnone, E. Vigna, M. Sachs, G. Hartmann, W. Birchmeier, Y. Daikuhara, H. Tsubouchi, F. Blasi, and P. M. Comoglio. 1992. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO (Eur. Mol. Biol. Organ.) J 11:4825-4833.
60. Kirchheimer, J. C., J. Wojta, G. Christ, and B. R. Binder. 1987. Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB (Fed. Am. Soc. Exp. Biol.) J. 1:125-128.
61. Rabban, S. A., A. P. Mazar, S. M. Berneir, M. Haq, I. Bolivar, J. Henkin, and D. Goltzman. 1992. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem. 267:14151-14156.